Wilfried Mutombo

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

Gérardo Priotto, S Kasparian, Wilfried Mutombo et al. · The Lancet · 2009 · 532 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +12

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness

Caecilia Schmid, Andrea Kuemmerle, Johannes Blum et al. · PLoS neglected tropical diseases · 2012 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +14

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study

Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard et al. · PLoS neglected tropical diseases · 2021 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14

How Clinical Research Can Contribute to Strengthening Health Systems in Low Resource Countries

Florent Mbo, Wilfried Mutombo, Digas Ngolo et al. · Tropical Medicine and Infectious Disease · 2020 · 23 citations · Full text

Public Health, Health Policy, Health Systems +13

Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo

Andrea Kuemmerle, Caecilia Schmid, Victor Kandé et al. · PLoS neglected tropical diseases · 2020 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16